The European Pharmacopoeia (Ph. Eur.) has published a major revision of general chapter 3.2.1: Glass containers for pharmaceutical use in Pharmeuropa 37.3.
This is the first significant update since 2019 and was led by the Glass (GLS) Working Party.
Key highlights include:
-
🔍 Clarified testing purposes for hydrolytic resistance (Tests A, B, and C), addressing frequent user questions.
-
💡 Modernised spectral transmission test for coloured glass, now based on wall thickness rather than container volume or closure type.
📣 The revised chapter is open for public consultation until end of September 2025. Stakeholders are encouraged to review and provide feedback.
